Patent ES-354093-A1 (ES)
Title: 2,alpha-dimenthyl-beta-ethyl-beta-(p-fluorophenyl)-ethylamines and the salts thereof
IPC: C07C49/807
Filed: 1968-05-20
Abstract: Novel [alpha],[alpha]-dimethyl-#-ethyl-#-(p-fluoro)-phenethyl-amines of the formula where R is H or CH 3 , and their acid addition salts, are obtained (a) by reducing the corresponding N-benzyl compounds with hydrogen in the presence of a catalyst, (b) by subjecting N - [[alpha],[alpha] - dimethyl - # - ethyl - # - (p - fluoro)- phenethyl]-formamide to hydrolysis in the presence of an acid or base catalyst or reducing it with LiAlH 4 or LAlH 4 -ACl 3 (c) by reducing 2,2-dimethyl-3-ethyl-3- (p-fluorophenyl)- aziridine using hydrogen in the presence of a noble metal catalyst (d) by reducing N- methylene - [alpha],[alpha] - dimethyl - # - ethyl - # - (pfluoro)-phenethylamine using NaBH 4 , Na in alcohol, Al amalgam, Mg-MgI 2 , LiAlH 4 or HCOOH or (e) by hydrolysing an N-arylidene- [alpha],[alpha] - dimethyl - # ethyl - # - (p - fluoro)- phenethyl-methylammonium salt. The free bases can be converted to acid addition salts by reaction with organic and inorganic acids. The free dl bases can be resolved into d and l isomers using the d- or l-form of tartaric acid in conventional manner. The preparation of starting materials is described as follows:- Fluorobenzene is reacted with isobutyryl chloride in the presence of AlCl 3 to form pfluoroisobutyrophenone which is reacted with ethyl magnesium bromide to yield 1-ethyl-1-(pfluorophenyl) - 2 - methylpropan - 1 - ol which is dehydrated to form 2-methyl-3-(p-fluorophenyl)- 2-pentene. This product is treated with benzonitrile to form N-[[alpha],[alpha]-dimethyl-#-ethyl-#-(pfluoro)phenethyl]-benzamide which is reduced with LiAlH 4 to N-benzyl-[alpha],[alpha]-dimethyl-#-ethyl-#- (p-fluoro)phenethylamine. A mixture of this compound and formaldehyde is treated with formic acid yielding N-benzyl-[alpha],[alpha]-N-trimethyl-#- ethyl - # - (p - fluoro) - phenethylamine. 1 - Ethyl- 1 - (p - fluorophenyl) - 2 - methylpropan 1 - ol is reacted with NaCN and acetic-sulphuric acid mixture to form N-[[alpha],[alpha]-dimethyl-#-ethyl-#-(pfluoro) - phenylethyl] - formamide. p - Fluoroisobutyrophenone, 1,1 - dimethylhydrazine and p-toluenesulphonic acid are refluxed to form pfluoroisobutyrophenone dimethylhydrazone which is reacted with methyl iodide to form the corresponding trimethylhydrazonium iodide which is reacted with sodium isopropoxide forming 2,2 - dimethyl - 3 - (p - fluorophenyl) - azirine this is reacted with EtMgBr to form 2,2-dimethyl - 3 - (pfluorophenyl) - 3 - ethylaziridine. dl - [alpha],[alpha] - Dimethyl - # - ethyl - # - (p - fluoro)- phenethylamine is refluxed with paraformaldehyde to form N-methylene-[alpha],[alpha]-dimethyl-#- ethyl-#-(p-fluoro)-phenethylamine. The same starting material is refluxed with benzaldehyde to form dl-N-benzylidene-[alpha],[alpha]-dimethyl-#-ethyl-# (p-fluoro)-phenethylamine which is reacted with CH 3 I to form the methiodide. Pharmaceutical compositions which exhibit an appetite-depressant or anorexic effect when administered orally or parenterally comprise as active ingredient a compound of the above general formula.